A.C.Camargo Cancer Center

What A.C.Camargo Cancer Center does

A.C.Camargo Cancer Center is a non-profit oncology hospital system operated by Fundação Antônio Prudente and headquartered in São Paulo, Brazil, delivering integrated cancer care across prevention, diagnosis, treatment, research, and post-cancer survivorship. Its service portfolio spans diagnostic medicine (laboratory, imaging, pathology), chemotherapy, radiotherapy, surgery, telemedicine, home specimen collection, clinical trials, and a dedicated Vida Pós-Câncer survivorship program, all delivered through multiple São Paulo units (Antônio Prudente, Itaim, Pires da Mota, Tamandaré) and supported by an International Research Center (CIPE), a Hospital Cancer Registry, a Teaching Portal, and an Innovation Hub. The center holds Qmentum International accreditation, ISO 14001 certification, PADI certification, ranks in the Scimago Institutions Rankings, and participates in the Brazilian Ministry of Health's PROADI SUS program.

The business model is multi-payer and non-profit. Revenue is generated through accepted health insurance plans (convênios), private patient billing (particular), SUS reimbursements via PROADI, and donations (including Nota Fiscal Paulista programs). A referring-physician channel for cellular therapy referral and a dedicated doctor-facing WhatsApp line extend referral-based demand, while telemedicine and home specimen collection broaden patient access. Customers are individual cancer patients served across the full care continuum, with horizontal segmentation by cancer type and a multidisciplinary reference-center model that organizes care by tumor specialty. The center is privately held by its foundation, has no disclosed funding rounds, no parent company, and no M&A activity in the source data.

The technology stack is service-delivery-oriented rather than software-product-oriented: appointment scheduling, exam results portal, telemedicine platform, and an open-innovation portal are the principal digital surfaces. The proprietary CIPE research infrastructure and Hospital Cancer Registry form the principal data and research assets, but no AI/ML products, patents, or commercialized technology platforms are disclosed in the available information.

Name

A.C.Camargo Cancer Center

Legal name

Fundação Antônio Prudente

Website

https://especializadoemvida.com.br

Company type

Private

Operating status

Operating

Short description

A.C.Camargo Cancer Center is a São Paulo-based, non-profit oncology hospital system operated by Fundação Antônio Prudente, delivering integrated cancer diagnosis, treatment, clinical research, education, and survivorship care to individual patients through multiple specialized units.

Ownership category

akta.pro rank

Product category

Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Offices of Physicians (62111), Medical and Diagnostic Laboratories (62151)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Oncology Telemedicine Platforms (HLALAGAH), Medical Oncology (HLAKAFAB), Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

Keywords

• Cancer treatment services
• Oncology diagnostics
• Radiation therapy services
• Clinical cancer research
• Oncology medical education

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Distribution channels4 records

Marketing channels5 records

Core offering

A.C.Camargo Cancer Center provides integrated oncology care through diagnostic medicine, chemotherapy, radiotherapy, and clinical studies, delivered across multiple hospital units in São Paulo. It complements treatment with telemedicine consultations, home specimen collection, patient and family support services, and post-cancer survivorship programs, and operates dedicated research (CIPE), education (Portal de Ensino), and innovation (Hub de Inovação) divisions under the Fundação Antônio Prudente non-profit foundation.

Product overview

A.C.Camargo Cancer Center is a specialized oncology hospital offering a comprehensive cancer care ecosystem. The center provides an integrated platform of services including diagnostic medicine (laboratory tests, imaging, pathology), treatment services (chemotherapy, radiotherapy, surgery), clinical studies, telemedicine consultations, and patient support programs. The organization operates multiple facilities in São Paulo and maintains research (CIPE - International Research Center), education (Teaching Portal), and innovation (Innovation Hub) divisions. Services are accessible through appointment scheduling, with health insurance verification and private billing options available.

Differentiator

Problem solved

Functional benefit

Products and services

• Telemedicine Consultations Remote oncology consultations that allow patients to connect with specialists via video or virtual visits, scheduled through the website. Targeted at cancer patients seeking specialist access without in-person visits.
• Diagnostic Medicine Advanced diagnostic services for cancer detection and monitoring, including laboratory tests, imaging, and pathology, with results delivered through an online portal.
• Chemotherapy Chemotherapy treatment scheduling and administration procedures for cancer patients across the center's units.
• Radiotherapy Radiation therapy treatment services for cancer patients, delivered as part of the center's oncology treatment portfolio.
• Home Specimen Collection (Coleta Domiciliar) Service that sends healthcare professionals to patients' homes for specimen collection, supporting diagnostic testing without travel.
• Clinical Studies (Clinical Trials) Ongoing clinical trial program providing cancer patients access to experimental treatments and oncology research studies, with enrollment managed through the website and oversight by an ethics committee.
• Patient Support Program (Apoio ao Paciente) Comprehensive patient and family support services including first-time assistance, immunization center, blood donation coordination, and patient safety programs.
• Post-Cancer Life Program (Vida Pós-Câncer) Specialized survivorship program supporting cancer patients with follow-up care and quality-of-life management after treatment completion.
• Health Insurance and Private Billing Services (Convênios) Administrative services covering health insurance verification, convênio authorization processing, and private (particular) budget requests for patients.
• Teaching Portal (Portal de Ensino) Educational platform offering oncology training, continuing education, and academic programs for medical professionals.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves6 records

Expansion highlights6 records

Regional players

• Hospital Italiano de Buenos Aires: Large Argentine academic hospital with a strong oncology service line and active research; comparable in scale and integrated care approach to A.C.Camargo but operates in a different South American market.
• Hospital Mãe de Deus: Oncology-capable hospital in southern Brazil (Rio Grande do Sul) offering integrated cancer care; comparable in service breadth but serves a different regional catchment than A.C.Camargo.

Broad incumbents

• Hospital Israelita Albert Einstein: Leading Brazilian premium hospital system in São Paulo with active oncology services, clinical research, and an innovation agenda; competes for the same high-acuity oncology patients and physician talent as A.C.Camargo.
• Memorial Sloan Kettering Cancer Center: US-based world-leading specialty cancer hospital with deep research and clinical trial pipelines; the international gold standard against which A.C.Camargo's oncology-only positioning is benchmarked.
• MD Anderson Cancer Center: Global benchmark for comprehensive cancer centers — combining hospital care, translational research, clinical trials, and education — and the international reference point for the cancer center model A.C.Camargo aspires to.
• Hospital Sírio-Libanês: High-end São Paulo-based general hospital with a strong oncology program, research institute (IEP), and teaching activities — overlaps with A.C.Camargo in oncology, research, and education but offers a much broader service portfolio.

Direct peers

• Instituto Nacional de Câncer (INCA): Brazilian Ministry of Health–affiliated national cancer institute providing prevention, treatment, research, and education; the principal public-sector comparator to A.C.Camargo for oncology capacity and SUS-linked activity.
• European Institute of Oncology (IEO): Milan-based integrated cancer center combining diagnosis, treatment, research, and education under one institution — directly analogous to A.C.Camargo's single-disease specialty hospital model in a different geography.
• Hospital de Câncer de Barretos: Brazil's other flagship oncology hospital network, operating multiple cancer centers with integrated prevention, diagnosis, treatment, research, and teaching — directly comparable to A.C.Camargo's comprehensive cancer center model in the same country.

Emerging players

• DASA (Diagnósticos da América): Brazil's largest diagnostics and hospital network with significant oncology-related imaging and lab services; overlaps with A.C.Camargo's diagnostic medicine and outpatient oncology offerings in the same market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/accamargocancercenter
• LinkedInlinkedin.com/company/accamargo

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about A.C.Camargo Cancer Center